BioMall
Brand Store/BDB Bioscience/BD PharmingenTM Alexa FluorTM 488 Mouse Anti-Human CD133
BD PharmingenTM Alexa FluorTM 488 Mouse Anti-Human CD133
GENERAL CATALOGUE

BD PharmingenTM Alexa FluorTM 488 Mouse Anti-Human CD133

567907 · 0.1 mg

BDB Bioscience · Cat: 567907

₹300 – ₹450 approx.This price excludes freight and taxes. Please RFQ to get the final price.

Reach 3+ verified distributors

Catalog No: 567907
Category: reagents
Pack Size: 0.1 mg
Brand: BDB Bioscience

Description

CD133 expression on retinoblastoma cell line and peripheral blood mononuclear cells PBMC Panel 1. Cells from the WERI-Rb-1 Retinoblastoma, ATCC HTB-169 cell line were stained with either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Cat. No. 565383; dashed line histogram or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Cat. No. 567907/567908 solid line histogram at 0.5 mug/test. The fluorescence histogram showing CD133 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable cells. Panel 2A. Human peripheral blood mononuclear cells PBMC were stained with BD Horizon CD34 APC-R700 antibody Cat. No. 659114 and either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Left Plot or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Right Plot at 0.5 mug/test. BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells before analysis. The pseudocolor density plot showing the correlated expression of CD133 or Ig Isotype control staining versus CD34 was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD negative peripheral blood lymphocytes PBL . Panel 2B. Human PBMC were similarly stained with BD Horizon BUV395 Mouse Anti-Human CD45 antibody Cat. No. 563791/563792 and either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Left Plot or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Right Plot at 0.5 mug/test followed by Cell Viability 7-AAD Solution addition before analysis. The pseudocolor density plot showing the correlated expression of CD45 versus CD133 or Ig Isotype control staining was similarly derived for viable PBL. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. CD133 expression on retinoblastoma cell line and peripheral blood mononuclear cells PBMC Panel 1. Cells from the WERI-Rb-1 Retinoblastoma, ATCC HTB-169 cell line were stained with either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Cat. No. 565383; dashed line histogram or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Cat. No. 567907/567908 solid line histogram at 0.5 mug/test. The fluorescence histogram showing CD133 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable cells. Panel 2A. Human peripheral blood mononuclear cells PBMC were stained with BD Horizon CD34 APC-R700 antibody Cat. No. 659114 and either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Left Plot or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Right Plot at 0.5 mug/test. BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells before analysis. The pseudocolor density plot showing the correlated expression of CD133 or Ig Isotype control staining versus CD34 was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD negative peripheral blood lymphocytes PBL . Panel 2B. Human PBMC were similarly stained with BD Horizon BUV395 Mouse Anti-Human CD45 antibody Cat. No. 563791/563792 and either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Left Plot or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Right Plot at 0.5 mug/test followed by Cell Viability 7-AAD Solution addition before analysis. The pseudocolor density plot showing the correlated expression of CD45 versus CD133 or Ig Isotype control staining was similarly derived for viable PBL. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific. Show More CD133 expression on retinoblastoma cell line and peripheral blood mononuclear cells PBMC Panel 1. Cells from the WERI-Rb-1 Retinoblastoma, ATCC HTB-169 cell line were stained with either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Cat. No. 565383; dashed line histogram or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Cat. No. 567907/567908 solid line histogram at 0.5 mug/test. The fluorescence histogram showing CD133 expression or Ig Isotype control staining was derived from gated events with the forward and side light-scatter characteristics of viable cells. Panel 2A. Human peripheral blood mononuclear cells PBMC were stained with BD Horizon CD34 APC-R700 antibody Cat. No. 659114 and either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Left Plot or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Right Plot at 0.5 mug/test. BD Via-Probe Cell Viability 7-AAD Solution Cat. No. 555815/555816 was added to cells before analysis. The pseudocolor density plot showing the correlated expression of CD133 or Ig Isotype control staining versus CD34 was derived from gated events with the forward and side light-scatter characteristics of viable 7-AAD negative peripheral blood lymphocytes PBL . Panel 2B. Human PBMC were similarly stained with BD Horizon BUV395 Mouse Anti-Human CD45 antibody Cat. No. 563791/563792 and either Alexa Fluor 488 Mouse IgG2b, kappa Isotype Control Left Plot or Alexa Fluor 488 Mouse Anti-Human CD133 antibody Right Plot at 0.5 mug/test followed by Cell Viability 7-AAD Solution addition before analysis. The pseudocolor density plot showing the correlated expression of CD45 versus CD133 or Ig Isotype control staining was similarly derived for viable PBL. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo software. Data shown on this Technical Data Sheet are not lot specific.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents